211. 左心低形成症候群 Hypoplastic left heart syndrome Clinical trials / Disease details
臨床試験数 : 21 / 薬物数 : 29 - (DrugBank : 9) / 標的遺伝子数 : 5 - 標的パスウェイ数 : 14
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT03079401 (ClinicalTrials.gov) | November 27, 2017 | 8/3/2017 | Mesoblast Stem Cell Therapy for Patients With Single Ventricle and Borderline Left Ventricle | Mesoblast Stem Cell Therapy for Patients With Single Ventricle and Borderline Left Ventricle | Hypoplastic Left Heart Syndrome;Atrioventricular Canal | Biological: MPC; rexlemestrocel-L | Boston Children's Hospital | NULL | Active, not recruiting | N/A | 5 Years | All | 19 | Phase 1/Phase 2 | United States |